Novel Wound Management

image28

Quthero's Technology

Quthero is committed to disrupting the ways we treat wounds today – from passive ‘dressing’ of wounds to active, rapid, healthy wound management. 


We have developed novel, effective and safe treatments for all types of wounds including wounds from cosmetic procedures, surgical wounds, burns, and chronic ulcers to effectively manage wounds and reduce complications and risks associated with slow healing (infection, pain, amputation and mortality).


Quthero’s patented platform technology enables full epithelial restoration, helping to close wounds quickly and with minimal scarring. Our novel wound management gel treats wounds in a potent, paradigm-shifting way with only a single application. This has been demonstrated in multiple pre-clinical animal models and human skin, where Quthero-treated wounds healed with minimal scarring and 60-200% faster than the wounds treated with currently marketed products.


Quthero’s platform technology effectively manages wounds in tissues other than skin as validated in cardiovascular, endothelial, cutaneous tissue, osteoblasts and hiPSC and published in 9 peer reviewed articles.


Our Team

Milica Radisic, PhD

image29

 

CEO, Scientific Founder

Chair of the Board


Professor, University of Toronto

Canada Research Chair

Fellow of the Royal Society of Canada 

Fellow AIMBE, MIT TR35

Co-Founder, TARA Biosystems

Susan Bruggemann, MBA

image30


COO, CFO



COO, Xylyx Bio, Inc.

Director Financial Planning and Analysis, Brightstar, Inc.

Director Finance, Kraft Foods, Inc.


Serena Mandla, BASc

image31

 

 CSO, Product Manager


Research Scientist and

Graduate Student in

Biomedical Engineering,

IBBME, University of Toronto

 


David Elmaleh, PhD

image32

 

Co-founder, Board Director and Business Advisor


Assoc. Prof. Harvard Medical School, Dir. CMC Mass. General Hospital,

CEO and Founder, AZTherapies,

Founder Molecular Insight, Mersana, PureTech Health.

Our Scientific Advisors

Jeff Karp, PhD

image33

Professor, Harvard Medical School

Co-founder: Skintifique, Gecko Biomedical, Alivio Therapeutics,

Frequency Therapeutics

Dennis Orgill, MD, PhD

image34

Professor of Surgery, Harvard Medical School

Medical Director, Brigham and Women's Hospital Wound Care Center 

Principal Investigator, Wound Healing & Tissue Engineering Laboratory


Leonard Miller, MD

image35

Clinical Instructor in Surgery, Harvard Medical School

Staff Surgeon, Beth Israel Deaconess Hospital

Founder,  Boston Center for Facial Rejuvenation

Jeff Biernaskie, PhD

image36

 Professor, University of Calgary

Calgary Firefighters Burn Treatment Society Chair in Skin Regeneration and Wound Healing

Our Business Advisors

Henry Kay, MS, MBA

image37

Strategic Marketing Consultant, Business Advisor and Angel Investor


40 years' experience in the medical industry in roles including R&D, International Marketing, Regulatory Affairs, and Strategic Planning for major pharmaceutical companies, including Schering-Plough, American Home Products, Sterling Drug and Allergan.



Subscribe

Sign up to hear from us.

Contact Us

Quthero, Inc.

Toronto,Ontario, Canada and Miami, FL, USA

Send Message

Cancel

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.